Background. Calcineurin inhibitors induce renal vasoconstriction and oliguria during acute toxicity. We previously demonstrated that the nonspecific adenosine receptor antagonist theophylline improved glomerular filtration rate (GFR) and renal blood flow in the setting of acute tacrolimus (TAC) toxicity. This study was undertaken to determine which of the known adenosine receptor subtypes is responsible for the observed effect of theophylline. Methods. The GFR was measured by clearance of 51 Cr-EDTA in anaesthetized, instrumented SpragueDawley rats at three time points: at baseline, 60 min after intravenous administration of TAC (0.05 mg/kg) or vehicle (V) and at 100 min after TAC or V. Either DMSO (n ¼ 5) or one of the three available specific adenosine receptor subtype antagonists 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 2 mg/kg, n ¼ 5), a selective A 1 receptor antagonist, 8-(3-chlorostyryl) caffeine (CSC, 2 mg/kg, n ¼ 4), a selective A 2a receptor antagonist and 3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-dihydropyridine-3,5 dicarboxylate (MRS1191, 1 mg/kg, n ¼ 5), a selective A 3 receptor antagonist, was administered intra-peritoneally prior to the final GFR measurement. Repeated measures analysis of variance was used to detect differences between groups (P<0.05). Results. Measured GFR declined by 30% from baseline 60 min after TAC. In DMSO treated animals, GFR decreased 51% from baseline at 100 min after TAC, but increased 45% from baseline at 100 min after TAC þ MRS1191. Conclusions. Only administration of the A 3 adenosine antagonist increased GFR following TAC, suggesting that this receptor mediates the effect of theophylline on GFR.Keywords: glomerular filtration rate; adenosine antagonist; tacrolimus; prograf; calcineurin inhibitor; adenosine; receptors; purinergic Tacrolimus (TAC) is a potent immunosuppressant which has significantly advanced the success of transplantation through control of rejection episodes; however, both the calcineurin inhibitor and its predecessor cyclosporine A induce renal vasoconstriction [1]. Adenosine is one reputed mediator of this effect of calcineurin inhibition as it is elevated in the blood of patients receiving cyclosporine A [2]. In several types of cultured cells, incubation with calcineurin inhibitors blocks the uptake of adenosine through inhibition of adenylyl cyclase activity [3,4]. Increased adenosine has been implicated in various nephropathies associated with vasoconstriction including those induced by contrast media, amphotericin and cisplatin [2,5]. Adenosine receptors are found throughout the body and play important regulatory roles in the control of vasomotor tone and inflammatory processes [6]. In the kidney, adenosine acutely constricts preglomerular vessels via A 1 receptor activation while dilating the efferent vessels by A 2a receptor activation [6,7]. Both A 1 and A 2a receptors are G-coupled proteins that regulate adenylyl cyclase activity albeit in opposite directions [6]. Activation of A 3 receptors, like the activation of A...